Skip to main content

Table 1 Comparison between the studied groups regarding serum levels of LH & TGF-B

From: Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways

Parameters Group F (P)
Control Benign Borderline Malignant  
LH (Mean ± SD) 8.7 ± 1.6 18.8 d ± 4.4 4.5 ± 0.9 3.7 ± 1.4 0.001*
TGF-B (Mean ± SD) 1347.4 ± 594.2 1039.0 ± 686.4 994 ± 547.6 894.0 ± 547.6 0.065
  1. F One Way ANOVA, d significantly different group (s), *P < 0.05 (significant)